Gavin Molinelli
Chairman at ACACIA RESEARCH CORPORATION
Net worth: 241 950 $ as of 30/03/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Smith | M | 51 |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 13 years |
Maureen O'Connell | F | 62 | 5 years | |
MJ McNulty | M | 46 | 2 years | |
Peter Feld | M | 45 |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 13 years |
Jonathan Sagal | M | 42 |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 13 years |
Geoff Ribar | M | 65 | 1 years | |
Isaac Kohlberg | M | 71 | 5 years | |
Kirsten Hoover | F | 45 | 3 years | |
Dumitrache Martinez | M | - | 8 years | |
Kevin S. Gorman | M | - | 8 years | |
Katharine Wolanyk | F | 61 | 5 years | |
Thomas Cusack | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 13 years |
John Formon | M | - | 9 years | |
Marc Booth | M | 66 | 6 years | |
Jennifer Graff | F | - | 13 years | |
Jason Soncini | M | 47 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael C. Burandt | M | 79 | 4 years | |
Sherri Lemmer | F | 56 | 10 years | |
James Schoeneck | M | 66 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 10 years |
Arthur Higgins | M | 68 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 3 years |
Mark Robert Mitchell | M | 62 |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | - |
Clifford Press | M | 69 | 4 years | |
Charles E. Hodges | M | 72 | 4 years | |
Gary W. Freels | M | 75 | 20 years | |
G. Humphrey | M | 79 | 9 years | |
William McKee | M | 62 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | - |
Sharon Larkin | F | 60 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 3 years |
Wes Golby | M | - | 2 years | |
Robert G. Savage | M | 70 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 1 years |
David B. Zenoff | M | 86 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 10 years |
Robert H. Yanker | M | 65 | 1 years | |
George Patrick Murphy | M | 71 | 3 years | |
Donald E. Lewis | M | - | - | |
Ronald Menezes | M | 61 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 1 years |
Jill Jene | M | 51 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 11 years |
Randall Hetland | M | - | - | |
Kara Hagerty | F | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 5 years |
Brian Powers | M | - | - | |
Thadd M. Vargas | M | 58 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 15 years |
Cristiano Amoruso | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | - |
Brian Hollenden | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | - |
Nikhil Oberoi | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | - |
Peter W. Schineller | M | 64 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 2 years |
Srinivas Rao | M | 55 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 3 years |
Doug Snyder | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 9 years |
Jeff Cino | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 2 years |
Richard Rosenstein | M | 59 | 3 years | |
Frank Geng | M | - |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value LP is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey Smith and Peter Feld in 2011 when Ramius LLC's activist value and opportunity business was spun-off as an independent firm. Ramius LLC maintains a significant minority interest in the firm. They are a subsidiary of Starboard Principal Co. LP. Starboard Value provides discretionary investment management services to private investment partnerships and offshore investment funds that are offered to investors on a private placement basis. | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 48 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gavin Molinelli
- Personal Network